Published in Surv Ophthalmol on July 04, 2006
Age-related macular degeneration. Lancet (2008) 3.34
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33
Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci (2008) 2.91
Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest Ophthalmol Vis Sci (2007) 2.36
An update on the genetics of age-related macular degeneration. Mol Vis (2007) 1.95
Choriocapillaris vascular dropout related to density of drusen in human eyes with early age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.85
Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2014) 1.76
Immunopathological aspects of age-related macular degeneration. Semin Immunopathol (2008) 1.63
Ophthalmic drug discovery: novel targets and mechanisms for retinal diseases and glaucoma. Nat Rev Drug Discov (2012) 1.52
The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One (2008) 1.44
Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol (2010) 1.42
Estimation and partition of heritability in human populations using whole-genome analysis methods. Annu Rev Genet (2013) 1.41
CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD. PLoS One (2009) 1.34
Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol (2009) 1.34
Age-related macular degeneration: genetic and environmental factors of disease. Mol Interv (2010) 1.24
Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. Ophthalmology (2008) 1.22
Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database Syst Rev (2008) 1.17
Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol (2014) 1.17
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
Human HtrA1 in the archived eyes with age-related macular degeneration. Trans Am Ophthalmol Soc (2007) 1.15
Genetic markers and biomarkers for age-related macular degeneration. Expert Rev Ophthalmol (2007) 1.15
HTRA1 promoter polymorphism predisposes Japanese to age-related macular degeneration. Mol Vis (2007) 1.14
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application. Graefes Arch Clin Exp Ophthalmol (2010) 1.12
LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis. Mol Vis (2010) 1.11
Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology (2012) 1.07
The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. Ophthalmology (2008) 1.07
Coding variant Met72Thr in the PEDF gene and risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis (2009) 1.04
SOD2 gene polymorphisms in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Mol Vis (2009) 1.04
Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration. PLoS One (2007) 1.02
Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One (2009) 0.97
Assessment of the contribution of CFH and chromosome 10q26 AMD susceptibility loci in a Russian population isolate. Br J Ophthalmol (2006) 0.96
The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Ophthalmology (2007) 0.96
Convergence of linkage, gene expression and association data demonstrates the influence of the RAR-related orphan receptor alpha (RORA) gene on neovascular AMD: a systems biology based approach. Vision Res (2009) 0.95
Genetics and molecular pathology of Stargardt-like macular degeneration. Prog Retin Eye Res (2010) 0.95
Role of ocular complement factor H in a murine model of choroidal neovascularization. Am J Pathol (2010) 0.95
Risk factors for age-related maculopathy. J Ophthalmol (2009) 0.95
Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration. Mol Vis (2009) 0.94
Genotype-phenotype associations: modulation by diet and obesity. Obesity (Silver Spring) (2008) 0.93
Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol (2011) 0.93
Retinal sphingolipids and their very-long-chain fatty acid-containing species. Invest Ophthalmol Vis Sci (2010) 0.92
C-reactive protein and CFH, ARMS2/HTRA1 gene variants are independently associated with risk of macular degeneration. Ophthalmology (2010) 0.92
Dietary compound score and risk of age-related macular degeneration in the age-related eye disease study. Ophthalmology (2009) 0.92
Age-related decline in VIP-positive parasympathetic nerve fibers in the human submacular choroid. Invest Ophthalmol Vis Sci (2007) 0.89
Detecting Genes and Gene-gene Interactions for Age-related Macular Degeneration with a Forest-based Approach. Stat Biopharm Res (2009) 0.88
Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration. Br J Ophthalmol (2008) 0.87
An association study of SERPING1 gene and age-related macular degeneration in a Han Chinese population. Mol Vis (2010) 0.87
Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease. Invest Ophthalmol Vis Sci (2011) 0.87
An ecological correlation study of late age-related macular degeneration and the complement factor H Y402H polymorphism. Invest Ophthalmol Vis Sci (2009) 0.85
Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS One (2011) 0.85
Associations between genetic polymorphisms of insulin-like growth factor axis genes and risk for age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.85
Genetic and environmental underpinnings to age-related ocular diseases. Invest Ophthalmol Vis Sci (2013) 0.85
Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J Biol Chem (2011) 0.85
Association of complement factor H Y402H polymorphism with phenotype of neovascular age related macular degeneration in Israel. Mol Vis (2008) 0.85
Alcohol and nicotine consumption exacerbates choroidal neovascularization by modulating the regulation of complement system. FEBS Lett (2008) 0.84
New era for personalized medicine: the diagnosis and management of age-related macular degeneration. Clin Experiment Ophthalmol (2009) 0.83
Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration. BMC Res Notes (2010) 0.83
Protective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration. Am J Ophthalmol (2009) 0.82
Genetic factors for choroidal neovascularization associated with high myopia. Invest Ophthalmol Vis Sci (2012) 0.82
Apolipoprotein E gene and age-related macular degeneration in a Chinese population. Mol Vis (2011) 0.81
Estimating cumulative pathway effects on risk for age-related macular degeneration using mixed linear models. BMC Bioinformatics (2015) 0.81
Ceramide signaling in retinal degeneration. Adv Exp Med Biol (2012) 0.81
Nanoparticle-based technologies for retinal gene therapy. Eur J Pharm Biopharm (2015) 0.81
Sunlight exposure, pigmentation, and incident age-related macular degeneration. Invest Ophthalmol Vis Sci (2014) 0.80
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration. Core Evid (2008) 0.80
Ethnic differences in the association of SERPING1 with age-related macular degeneration and polypoidal choroidal vasculopathy. Sci Rep (2015) 0.80
Surgical approaches to gene and stem cell therapy for retinal disease. Hum Gene Ther (2011) 0.79
Plasticity in the human visual cortex: an ophthalmology-based perspective. Biomed Res Int (2013) 0.78
Clinical applications of age-related macular degeneration genetics. Cold Spring Harb Perspect Med (2014) 0.78
Association of PEDF polymorphisms with age-related macular degeneration and polypoidal choroidal vasculopathy: a systematic review and meta-analysis. Sci Rep (2015) 0.78
Neural Stem Cells Derived by Small Molecules Preserve Vision. Transl Vis Sci Technol (2013) 0.78
Dry age-related macular degeneration: A currently unmet clinical need. Intractable Rare Dis Res (2012) 0.78
Genetic risk, ethnic variations and pharmacogenetic biomarkers in age-related macular degeneration and polypoidal choroidal vasculopathy. Expert Rev Ophthalmol (2013) 0.77
Methylnitrosourea (MNU)-induced retinal degeneration and regeneration in the zebrafish: histological and functional characteristics. J Vis Exp (2014) 0.77
Association of complement factor H gene polymorphisms with age-related macular egeneration susceptibility. Int J Clin Exp Pathol (2015) 0.77
Apolipoprotein E epsilon4 offers protection against age-related macular degeneration. Med Hypotheses (2006) 0.77
Sphingolipid profile alters in retinal dystrophic P23H-1 rats and systemic FTY720 can delay retinal degeneration. J Lipid Res (2016) 0.76
Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration? Autoimmun Rev (2017) 0.76
T-helper-associated cytokines expression by peripheral blood mononuclear cells in patients with polypoidal choroidal vasculopathy and age-related macular degeneration. BMC Ophthalmol (2016) 0.76
Novel endogenous glycan therapy for retinal diseases: safety, in vitro stability, ocular pharmacokinetic modeling, and biodistribution. AAPS J (2014) 0.75
Association between SERPING1 rs2511989 polymorphism and age-related macular degeneration: Meta-analysis. Int J Ophthalmol (2015) 0.75
Evaluation of 10 AMD Associated Polymorphisms as a Cause of Choroidal Neovascularization in Highly Myopic Eyes. PLoS One (2016) 0.75
Gene expression levels of the insulin-like growth factor family in patients with AMD before and after ranibizumab intravitreal injections. Clin Interv Aging (2017) 0.75
Association between polymorphism rs11200638 in the HTRA1 gene and the response to anti-VEGF treatment of exudative AMD: a meta-analysis. BMC Ophthalmol (2017) 0.75
Axial length and subfoveal choroidal thickness in individuals with age-related macular degeneration. Taiwan J Ophthalmol (2015) 0.75
Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med (2008) 19.71
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet (2006) 7.49
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet (2007) 4.23
Age-related macular degeneration. Lancet (2012) 4.17
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet (2011) 3.55
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A (2010) 3.33
Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet (2008) 3.29
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
A genomewide scan for age-related macular degeneration provides evidence for linkage to several chromosomal regions. Am J Hum Genet (2003) 3.23
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02
CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. Ophthalmology (2008) 2.90
The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis. Am J Epidemiol (2012) 2.87
Dissecting the phenotype in genome-wide association studies of psychiatric illness. Br J Psychiatry (2009) 2.65
Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: an extended follow-up. J Clin Oncol (2005) 2.37
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst (2007) 2.32
The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol (2007) 2.12
Prevalence of advanced colorectal neoplasia in white and black patients undergoing screening colonoscopy in a safety-net hospital. Ann Intern Med (2013) 2.04
Correction of phenotype misclassification based on high-discrimination genetic predictive risk models. Epidemiology (2012) 2.01
Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet (2011) 1.98
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. Invest Ophthalmol Vis Sci (2009) 1.86
Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening. Cancer Epidemiol Biomarkers Prev (2012) 1.76
Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy. Arch Ophthalmol (2004) 1.63
Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. Invest Ophthalmol Vis Sci (2012) 1.63
A discordant sib-pair linkage analysis of age-related macular degeneration. Ophthalmic Genet (2005) 1.51
The Your Disease Risk Index for colorectal cancer is an inaccurate risk stratification tool for advanced colorectal neoplasia at screening colonoscopy. Cancer Prev Res (Phila) (2012) 1.48
Genetic epidemiology: successes and challenges of genome-wide association studies using the example of age-related macular degeneration. Am J Ophthalmol (2010) 1.48
Nocturnal risk of gout attacks. Arthritis Rheumatol (2015) 1.46
Cause-specific mortality in long-term survivors of retinoblastoma. J Natl Cancer Inst (2009) 1.42
Review of genetics in age related macular degeneration. Semin Ophthalmol (2007) 1.37
Associations of CFHR1-CFHR3 deletion and a CFH SNP to age-related macular degeneration are not independent. Nat Genet (2010) 1.35
The LOC387715 gene, smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2007) 1.30
Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.30
Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology (2010) 1.29
The epidemiology of age-related macular degeneration. Int Ophthalmol Clin (2004) 1.25
Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr (2010) 1.25
A QTL genome scan of the metabolic syndrome and its component traits. BMC Genet (2003) 1.24
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol (2010) 1.19
Evidence of association of APOE with age-related macular degeneration: a pooled analysis of 15 studies. Hum Mutat (2011) 1.17
A new scale measuring psychologic impact of genetic susceptibility testing for Alzheimer disease. Alzheimer Dis Assoc Disord (2009) 1.16
Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes. Ophthalmology (2012) 1.16
A prospective study of diabetes, lifestyle factors, and glaucoma among African-American women. Ann Epidemiol (2011) 1.15
Complement factor D in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 1.14
Examination of NRCAM, LRRN3, KIAA0716, and LAMB1 as autism candidate genes. BMC Med Genet (2004) 1.10
Autism and serotonin transporter gene polymorphisms: a systematic review and meta-analysis. Am J Med Genet B Neuropsychiatr Genet (2008) 1.09
Aid-assisted decision making and colorectal cancer screening: a randomized controlled trial. Am J Prev Med (2012) 1.08
Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. Ophthalmology (2013) 1.08
Fertility therapies, infertility and autism spectrum disorders in the Nurses' Health Study II. Paediatr Perinat Epidemiol (2012) 1.05
Hormone therapy and age-related macular degeneration: the Women's Health Initiative Sight Exam Study. Arch Ophthalmol (2006) 1.03
Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective. Nicotine Tob Res (2003) 1.01
Genetic profile for five common variants associated with age-related macular degeneration in densely affected families: a novel analytic approach. Eur J Hum Genet (2009) 1.00
Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease. Alzheimers Dement (2008) 1.00
The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study. Eur J Hum Genet (2010) 0.98
Increased risk of secondary uterine leiomyosarcoma in hereditary retinoblastoma. Gynecol Oncol (2011) 0.97
rs5888 variant of SCARB1 gene is a possible susceptibility factor for age-related macular degeneration. PLoS One (2009) 0.97
Social service barriers delay care among women with abnormal cancer screening. J Gen Intern Med (2013) 0.96
Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease. Genet Med (2012) 0.95
Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses' Health Study II. Autism Res (2011) 0.94
Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. Am J Ophthalmol (2011) 0.93
Association between reproductive and hormonal factors and age-related maculopathy in postmenopausal women. Am J Ophthalmol (2002) 0.93
Kidney function, albuminuria and age-related macular degeneration in NHANES III. Nephrol Dial Transplant (2011) 0.93
Paternal age increases the risk for autism in an Iranian population sample. Mol Autism (2010) 0.92
Geographic atrophy in age-related macular degeneration and TLR3. N Engl J Med (2009) 0.91
Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease. J Genet Couns (2008) 0.89
Tobacco use in adult long-term survivors of retinoblastoma. Cancer Epidemiol Biomarkers Prev (2006) 0.89
Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease. J Health Commun (2009) 0.87
Maternal early life factors associated with hormone levels and the risk of having a child with an autism spectrum disorder in the nurses health study II. J Autism Dev Disord (2011) 0.87
Dietary glycemic load and risk of age-related cataract. Am J Clin Nutr (2004) 0.87
Cancer screening practices of adult survivors of retinoblastoma at risk of second cancers. Cancer (2008) 0.85
Maternal dietary fat intake in association with autism spectrum disorders. Am J Epidemiol (2013) 0.84
Automated discovery and quantification of image-based complex phenotypes: a twin study of drusen phenotypes in age-related macular degeneration. Invest Ophthalmol Vis Sci (2011) 0.83
Impact of patient and navigator race and language concordance on care after cancer screening abnormalities. Cancer (2015) 0.83
Common genetic variation in the GAD1 gene and the entire family of DLX homeobox genes and autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet (2010) 0.82
Genotype-phenotype analysis of ABCR variants in macular degeneration probands and siblings. Invest Ophthalmol Vis Sci (2002) 0.82
Genetic factors for choroidal neovascularization associated with high myopia. Invest Ophthalmol Vis Sci (2012) 0.82
Dietary folate, B vitamins, genetic susceptibility and progression to advanced nonexudative age-related macular degeneration with geographic atrophy: a prospective cohort study. Am J Clin Nutr (2016) 0.81
Multiple barriers delay care among women with abnormal cancer screening despite patient navigation. J Womens Health (Larchmt) (2014) 0.81
Cystoid macular edema without macular thickening: a retrospective optical coherence tomographic study. Retina (2010) 0.81
Sex-specific association of a common variant of the XG gene with autism spectrum disorders. Am J Med Genet B Neuropsychiatr Genet (2013) 0.80
A study of the prevalence and risk factors leading to HIV infection among a sample of street children and youth of Kathmandu. AIDS Res Ther (2012) 0.79
Smoking cessation and risk of cataract extraction among US women and men. Am J Epidemiol (2002) 0.78
Brief report: no association between parental age and extreme social-communicative autistic traits in the general population. J Autism Dev Disord (2011) 0.76
Risk of cataract extraction among adult retinoblastoma survivors. Arch Ophthalmol (2009) 0.75
(Epi)Genetic analyses of age-related macular degeneration: case-control and discordant twin studies. Hum Hered (2014) 0.75
To Correct or Not to Correct-and How. Epidemiology (2012) 0.75
Diagnosis and Follow-Up of Nonexudative Choroidal Neovascularization With Multiple Optical Coherence Tomography Angiography Devices: A Case Report. Ophthalmic Surg Lasers Imaging Retina (2016) 0.75
Factors affecting recall of different types of personal genetic information about Alzheimer's disease risk: the REVEAL study. Public Health Genomics (2015) 0.75
Impact of depression on the intensity of patient navigation for women with abnormal cancer screenings. J Health Care Poor Underserved (2014) 0.75
Increased risk of recurrent gout attacks with hospitalization. Am J Med (2013) 0.75
Choroidal and cutaneous melanoma: distinctly different cousins. Ophthalmic Epidemiol (2005) 0.75
Analysis of Choroidal and Retinal Vasculature in Inherited Retinal Degenerations Using Optical Coherence Tomography Angiography. Ophthalmic Surg Lasers Imaging Retina (2016) 0.75
Regular aspirin use and risk of age-related macular degeneration. Am J Ophthalmol (2013) 0.75